OPKO Health to Acquire Uruguayan Pharmaceutical Company; Terms Undisclosed
December 16, 2013 at 08:35 AM EST
Acquisition of Laboratorio Arama de Uruguay Limitada Will Add to Growing South American Presence in Important Mercosur Market Provides Platform for Near-Term Launch of 4Kscore™ Prostate Cancer Test and Enhances Commercial Synergies Amongst OPKO Units OPKO Health (NYSE: OPK ) has entered into an agreement to acquire Laboratorio
